These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 21864901)
1. Intracellular delivery of paclitaxel using oil-free, shell cross-linked HSA--multi-armed PEG nanocapsules. Lee JY; Bae KH; Kim JS; Nam YS; Park TG Biomaterials; 2011 Nov; 32(33):8635-44. PubMed ID: 21864901 [TBL] [Abstract][Full Text] [Related]
2. Oil-encapsulating PEO-PPO-PEO/PEG shell cross-linked nanocapsules for target-specific delivery of paclitaxel. Bae KH; Lee Y; Park TG Biomacromolecules; 2007 Feb; 8(2):650-6. PubMed ID: 17291088 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation. Zhang L; He Y; Ma G; Song C; Sun H Nanomedicine; 2012 Aug; 8(6):925-34. PubMed ID: 22101107 [TBL] [Abstract][Full Text] [Related]
4. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
5. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo. Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115 [TBL] [Abstract][Full Text] [Related]
6. Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Wu L; Tang C; Yin C Drug Dev Ind Pharm; 2010 Apr; 36(4):439-48. PubMed ID: 19824865 [TBL] [Abstract][Full Text] [Related]
7. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity. Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114 [TBL] [Abstract][Full Text] [Related]
8. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel. Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643 [TBL] [Abstract][Full Text] [Related]
9. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618 [TBL] [Abstract][Full Text] [Related]
10. Self-assembled core-shell vascular-targeted nanocapsules for temporal antivasculature and anticancer activities. Wang Z; Ho PC Small; 2010 Nov; 6(22):2576-83. PubMed ID: 20976704 [TBL] [Abstract][Full Text] [Related]
11. Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature. Yin J; Li Z; Yang T; Wang J; Zhang X; Zhang Q J Drug Target; 2011 Jan; 19(1):25-36. PubMed ID: 20233083 [TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes. Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917 [TBL] [Abstract][Full Text] [Related]
13. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug. Jang MK; Jeong YI; Nah JW Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624 [TBL] [Abstract][Full Text] [Related]
14. Self-assembled PEGylated albumin nanoparticles (SPAN) as a platform for cancer chemotherapy and imaging. Lee JE; Kim MG; Jang YL; Lee MS; Kim NW; Yin Y; Lee JH; Lim SY; Park JW; Kim J; Lee DS; Kim SH; Jeong JH Drug Deliv; 2018 Nov; 25(1):1570-1578. PubMed ID: 30044159 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530 [TBL] [Abstract][Full Text] [Related]
16. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy. Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344 [TBL] [Abstract][Full Text] [Related]
17. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434 [TBL] [Abstract][Full Text] [Related]
18. Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel. Yang R; Meng F; Ma S; Huang F; Liu H; Zhong Z Biomacromolecules; 2011 Aug; 12(8):3047-55. PubMed ID: 21726090 [TBL] [Abstract][Full Text] [Related]
19. Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel. Yin T; Cai H; Liu J; Cui B; Wang L; Yin L; Zhou J; Huo M Eur J Pharm Sci; 2016 Feb; 83():79-87. PubMed ID: 26699227 [TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy. Oh KS; Song JY; Cho SH; Lee BS; Kim SY; Kim K; Jeon H; Kwon IC; Yuk SH J Control Release; 2010 Dec; 148(3):344-50. PubMed ID: 20797418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]